SCHEMBL24533910

SCHEMBL24533910

CC(C)(C)Cc1ccc(B2OC(C)(C)C(C)(C)O2)s1

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.35
LPL P06858 9/20 0.34
LIPG Q9Y5X9 9/20 0.34
FFAR1 O14842 1/20 0.32
F11 P03951 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23247372 0.81 CYP2A6 (0.37) USP30LPLLIPGF11
SCHEMBL120211 0.79 LPL (0.42) USP30LPLLIPGF11
SCHEMBL3348299 0.79 LPL (0.36) LPLLIPGF11
SCHEMBL16600323 0.77 LPL (0.50) USP30LPLLIPGF11
SCHEMBL1164825 0.76 USP30 (0.37) USP30LIPGF11
SCHEMBL586870 0.75 LPL (0.34) USP30LPLLIPGFFAR1
SCHEMBL13976523 0.75 LPL (0.47) LPLLIPG
SCHEMBL12784899 0.75 ESR2 (0.36) LPLLIPG
SCHEMBL12845998 0.74 USP30 (0.36) USP30LPLLIPGFFAR1
SCHEMBL390494 0.74 LPL (0.40) USP30LPLLIPGF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220194974-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-06-23 US disclosed
CN-114621294-A Organic electroluminescent material and device 环球展览公司 2022-06-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220194974-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OTC USP30 4113/4885LPL 270/4885LIPG 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.